Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001325076 | SCV001516053 | uncertain significance | Deficiency of alpha-mannosidase | 2022-07-05 | criteria provided, single submitter | clinical testing | This sequence change affects codon 103 of the MAN2B1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MAN2B1 protein. This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with MAN2B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1024843). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001325076 | SCV002086945 | uncertain significance | Deficiency of alpha-mannosidase | 2020-02-28 | no assertion criteria provided | clinical testing |